These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25047306)

  • 61. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
    Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
    J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.
    Weintraub D; Taraborelli D; Morales KH; Duda JE; Katz IR; Stern MB
    J Neuropsychiatry Clin Neurosci; 2006; 18(3):377-83. PubMed ID: 16963587
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: a 12-week, open-label prospective trial.
    Park HY; Lee BJ; Kim JH; Bae JN; Hahm BJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):318-23. PubMed ID: 22142651
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M; Murphy CF; Meyers BS
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial.
    Findling RL; Robb A; Bose A
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):468-80. PubMed ID: 24041408
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B; Andersen HF; Dolberg OT
    Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC).
    Ostergaard SD; Bech P; Trivedi MH; Wisniewski SR; Rush AJ; Fava M
    J Affect Disord; 2014 Jul; 163():18-24. PubMed ID: 24836083
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Placebo response and antidepressant response.
    Alexopoulos GS; Kanellopoulos D; Murphy C; Gunning-Dixon F; Katz R; Heo M
    Am J Geriatr Psychiatry; 2007 Feb; 15(2):149-58. PubMed ID: 17272735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder.
    Rothschild AJ; Raskin J; Wang CN; Marangell LB; Fava M
    Compr Psychiatry; 2014 Jan; 55(1):1-10. PubMed ID: 24268564
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reward-related decision making in older adults: relationship to clinical presentation of depression.
    McGovern AR; Alexopoulos GS; Yuen GS; Morimoto SS; Gunning-Dixon FM
    Int J Geriatr Psychiatry; 2014 Nov; 29(11):1125-31. PubMed ID: 25306937
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Apathy After Stroke: Incidence, Symptom Trajectory, and Impact on Quality of Life and Disability.
    Pallucca C; Lisiecka-Ford DM; Wood L; Abul A; Jolly AA; Tozer DJ; Bell S; Forster A; Morris RG; Markus HS
    Neurology; 2024 Feb; 102(3):e208052. PubMed ID: 38207223
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Somatic and anxiety symptoms of depression are associated with disability in late life depression.
    Morin RT; Nelson C; Bickford D; Insel PS; Mackin RS
    Aging Ment Health; 2020 Aug; 24(8):1225-1228. PubMed ID: 30945553
    [No Abstract]   [Full Text] [Related]  

  • 73. The course of apathy in late-life depression treated with electroconvulsive therapy; a prospective cohort study.
    Carlier A; van Exel E; Dols A; Bouckaert F; Sienaert P; Ten Kate M; Wattjes MP; Vandenbulcke M; Stek ML; Rhebergen D
    Int J Geriatr Psychiatry; 2018 May; ():. PubMed ID: 29851173
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The importance of a multidimensional approach to the preclinical study of major depressive disorder and apathy.
    Jackson MG; Robinson ESJ
    Emerg Top Life Sci; 2022 Dec; 6(5):479-489. PubMed ID: 36413089
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The organization of the stress system and its dysregulation in depressive illness.
    Gold PW
    Mol Psychiatry; 2015 Feb; 20(1):32-47. PubMed ID: 25486982
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Levomilnacipran for the treatment of major depressive disorder: a review.
    Asnis GM; Henderson MA
    Neuropsychiatr Dis Treat; 2015; 11():125-35. PubMed ID: 25657584
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes of operative and nonoperative treatment of 3- and 4-part proximal humeral fractures in elderly: a 10-year retrospective cohort study.
    Brouwer ME; Reininga IHF; El Moumni M; Wendt KW
    Eur J Trauma Emerg Surg; 2019 Feb; 45(1):131-138. PubMed ID: 29285612
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pain intensity is associated with both performance-based disability and self-reported disability in a sample of older adults attending primary health care centers.
    Silva AG; Queirós A; Cerqueira M; Rocha NP
    Disabil Health J; 2014 Oct; 7(4):457-65. PubMed ID: 25224986
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Self-Reported Disability: Association With Lower Extremity Performance and Other Determinants in Older Adults Attending Primary Care.
    Silva AG; Queirós A; Sa-Couto P; Rocha NP
    Phys Ther; 2015 Dec; 95(12):1628-37. PubMed ID: 26023215
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of muscle mass and body fat on disability among older adults: A cross-national analysis.
    Tyrovolas S; Koyanagi A; Olaya B; Ayuso-Mateos JL; Miret M; Chatterji S; Tobiasz-Adamczyk B; Koskinen S; Leonardi M; Haro JM
    Exp Gerontol; 2015 Sep; 69():27-35. PubMed ID: 26048566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.